# Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV

> **NCT04434417** · — · COMPLETED · sponsor: **European Institute of Oncology** · enrollment: 1000 (actual)

## Conditions studied

- COVID

## Interventions

- **DEVICE:** 2019-nCoV IgG/IgM Rapid Test Cassette

## Key facts

- **NCT ID:** NCT04434417
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-15
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2022-05-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434417, "Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04434417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*